Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Study carried out in the Clinical and Analytical Unit of the Department of Pharmacology and Toxicology of the Faculty of Medicine of the Autonomous University of Nuevo León, with the objective of comparing the bioavailability (Cmax, AUC) of an oral formulation containing Etoricoxib 90 mg / Tramadol 50 mg in combination with that of two oral formulations, Etoricoxib 90 mg or Tramadol 50 mg, administered as a single dose, in healthy subjects under fasting conditions.
Epistemonikos ID: 8bf49295418e0dff8c3dc287514429ccadf0ba3b
First added on: May 13, 2024